| scholarly article | Q13442814 |
| P50 | author | Patrick Concannon | Q30501095 |
| Marinela Capanu | Q30501111 | ||
| William David Foulkes | Q37829195 | ||
| Maxime P Vallée | Q39970007 | ||
| Leslie Bernstein | Q60607806 | ||
| Marc Tischkowitz | Q66439010 | ||
| P2093 | author name string | Sean V Tavtigian | |
| Jonine L Bernstein | |||
| Xiaolin Liang | |||
| Colin B Begg | |||
| Lili Li | |||
| Nelly Sabbaghian | |||
| WECARE Study Collaborative Group | |||
| P2860 | cites work | PALB2 is an integral component of the BRCA complex required for homologous recombination repair | Q24316113 |
| PALB2 regulates recombinational repair through chromatin association and oligomerization | Q24322952 | ||
| PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene | Q24615080 | ||
| Analysis of PALB2/FANCN-associated breast cancer families | Q24683771 | ||
| Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study | Q24794680 | ||
| Penetrance analysis of the PALB2 c.1592delT founder mutation | Q27851443 | ||
| A method and server for predicting damaging missense mutations | Q27860835 | ||
| Novel germline PALB2 truncating mutations in African American breast cancer patients | Q28741002 | ||
| Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm | Q29547194 | ||
| Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical modeling | Q30426205 | ||
| Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. | Q30432372 | ||
| A novel germline PALB2 deletion in Polish breast and ovarian cancer patients | Q33528298 | ||
| Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer | Q33810128 | ||
| PALB2/FANCN: Recombining Cancer and Fanconi Anemia | Q34168415 | ||
| Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. | Q34541051 | ||
| Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer | Q34597168 | ||
| A PALB2 mutation associated with high risk of breast cancer | Q34613667 | ||
| Human Splicing Finder: an online bioinformatics tool to predict splicing signals | Q34973311 | ||
| Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2 1100delC in 1,828 bilateral breast cancers and 7,030 controls | Q37307305 | ||
| PALB2 mutations in familial breast and pancreatic cancer | Q37332757 | ||
| High-resolution DNA melting analysis: advancements and limitations | Q37500321 | ||
| Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer | Q37557629 | ||
| PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2. | Q39827885 | ||
| Classification of rare missense substitutions, using risk surfaces, with genetic- and molecular-epidemiology applications. | Q41985080 | ||
| Kin-cohort evaluation of relative risks of genetic variants | Q48018659 | ||
| A note on the estimation of relative risks of rare genetic susceptibility markers. | Q52892692 | ||
| BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer. | Q54603929 | ||
| A recurrent mutation in PALB2 in Finnish cancer families. | Q55043120 | ||
| Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families | Q57882113 | ||
| P433 | issue | 4 | |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 674-680 | |
| P577 | publication date | 2012-02-15 | |
| P1433 | published in | Human Mutation | Q5937269 |
| P1476 | title | Rare germline mutations in PALB2 and breast cancer risk: a population-based study | |
| P478 | volume | 33 |
| Q34521706 | A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer |
| Q36043159 | ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry |
| Q39382156 | ATM, radiation, and the risk of second primary breast cancer |
| Q34917808 | Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases |
| Q31167050 | Assessment of PALB2 as a candidate melanoma susceptibility gene |
| Q38776757 | Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study |
| Q51543949 | Association of PALB2 sequence variants with the risk of early-onset breast cancer in patients from Turkey. |
| Q35068734 | Association of PALB2 sequence variants with the risk of familial and early-onset breast cancer in a South-American population |
| Q37684672 | Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. |
| Q57420847 | Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study |
| Q24338777 | Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair |
| Q87081857 | Comprehensive sequencing of PALB2 in patients with breast cancer suggests PALB2 mutations explain a subset of hereditary breast cancer |
| Q41073736 | Compromised BRCA1-PALB2 interaction is associated with breast cancer risk. |
| Q55437668 | Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer. |
| Q34542998 | Contribution of the PALB2 c.2323C>T [p.Q775X] founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent |
| Q93164325 | Criteria of the German Consortium for Hereditary Breast and Ovarian Cancer for the Classification of Germline Sequence Variants in Risk Genes for Hereditary Breast and Ovarian Cancer |
| Q48103408 | Development of a novel PTT assay for mutation detection in PALB2 large exons and PALB2 screening in medullary breast cancer |
| Q90226214 | Differences in physician opinions about controversial issues surrounding contralateral prophylactic mastectomy (CPM): A survey of physicians from accredited breast centers in the United States |
| Q34938728 | Evaluation of the need for routine clinical testing of PALB2 c.1592delT mutation in BRCA negative Northern Finnish breast cancer families |
| Q57284117 | Familial breast cancer and DNA repair genes: insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing |
| Q36915151 | Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer |
| Q85247141 | Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel |
| Q51362287 | Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer. |
| Q38252487 | Genetic counseling for Fanconi anemia: crosslinking disciplines. |
| Q36144711 | Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition. |
| Q35106767 | Growing recognition of the role for rare missense substitutions in breast cancer susceptibility |
| Q38266306 | Hereditary breast cancer syndromes and genetic testing |
| Q39657506 | Hereditary breast cancer: the era of new susceptibility genes |
| Q37305285 | Heterozygous mutations in PALB2 cause DNA replication and damage response defects |
| Q34983596 | Inherited predisposition to breast cancer among African American women |
| Q56697958 | Mutation analysis of PALB2 gene in French breast cancer families |
| Q34178875 | Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada |
| Q35972599 | Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry |
| Q37074279 | PALB2 and breast cancer: ready for clinical translation! |
| Q36303235 | PALB2 mutations in BRCA1/2-mutation negative breast and ovarian cancer patients from Poland |
| Q36202233 | PALB2 mutations in breast cancer patients from a multi-ethnic region in northwest China |
| Q60315437 | PALB2 sequencing in Italian familial breast cancer cases reveals a high-risk mutation recurrent in the province of Bergamo |
| Q26751309 | PALB2: research reaching to clinical outcomes for women with breast cancer |
| Q47102174 | Perturbation of PALB2 function by the T413S mutation found in small cell lung cancer |
| Q44242400 | Prevalence of PALB2 mutation c.509_510delGA in unselected breast cancer patients from Central and Eastern Europe |
| Q36903452 | Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families |
| Q35964605 | Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls |
| Q55280273 | Prevalence of deleterious mutations among patients with breast cancer referred for multigene panel testing in a Romanian population. |
| Q28730692 | Rare mutations in XRCC2 increase the risk of breast cancer |
| Q47755879 | Targeted massively parallel sequencing characterises the mutation spectrum of PALB2 in breast and ovarian cancer cases from Poland and Ukraine |
| Q54269445 | The incidence of PALB2 c.3113G>A in women with a strong family history of breast and ovarian cancer attending familial cancer centres in Australia. |
| Q37003285 | Tumour morphology predicts PALB2 germline mutation status |
| Q92994868 | Two truncating variants in FANCC and breast cancer risk |
Search more.